Exam Details
Subject | dosage form design –i | |
Paper | ||
Exam / Course | b.pharm | |
Department | ||
Organization | Gujarat Technological University | |
Position | ||
Exam Date | April, 2016 | |
City, State | gujarat, ahmedabad |
Question Paper
Seat No.: Enrolment No.
GUJARAT TECHNOLOGICAL UNIVERSITY
B.PHARM- SEMESTER-VII • EXAMINATION WINTER-2016
Subject Code: 270001 Date: 17/11/2016
Subject Name: Dosage Form Design- I
Time: 10.30 am 01.30 pm Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Define polymorphism. Explain its importance in preformulation study with
example.
06
Write a brief note on overages.
05
Describe the Accelerated stability study with its limitation.
05
Q.2
Discuss Pharmaceutical application of Prodrug.
06
Discuss the role of diluents in solid dosage form.
05
Write a note on Preservatives.
05
Q.3
Explain the physicochemical properties of drug substance that affect the absorption of drug.
06
Write a note on volume of distribution.
05
Discuss the Photolysis reaction in detail.
05
Q.4
Discuss the factor affecting renal clearance.
06
Describe USP Type-II dissolution apparatus.
05
Write a note on BCS classification system.
05
Q.5
Discuss the effect of container and closures on stability of Pharmaceutical dosage form.
06
Explain Latin square cross over design in Bioequivalence study.
05
Discuss the criteria for waivers of in vivo Bioequivalence studies.
05
Q. 6
Write a note on Bracketing matrixing design in stability study.
06
Write a note on disintegrating agents.
05
Discuss the role of solubility in Preformulation study.
05
Q.7
Write a note on Plasma Protein Drug Binding.
06
Write a note on similarity factor and difference factor in dissolution profile comparison.
05
Discuss Drug-Excipients compatibility study in detail
05
GUJARAT TECHNOLOGICAL UNIVERSITY
B.PHARM- SEMESTER-VII • EXAMINATION WINTER-2016
Subject Code: 270001 Date: 17/11/2016
Subject Name: Dosage Form Design- I
Time: 10.30 am 01.30 pm Total Marks: 80
Instructions:
1. Attempt any five questions.
2. Make suitable assumptions wherever necessary.
3. Figures to the right indicate full marks.
Q.1
Define polymorphism. Explain its importance in preformulation study with
example.
06
Write a brief note on overages.
05
Describe the Accelerated stability study with its limitation.
05
Q.2
Discuss Pharmaceutical application of Prodrug.
06
Discuss the role of diluents in solid dosage form.
05
Write a note on Preservatives.
05
Q.3
Explain the physicochemical properties of drug substance that affect the absorption of drug.
06
Write a note on volume of distribution.
05
Discuss the Photolysis reaction in detail.
05
Q.4
Discuss the factor affecting renal clearance.
06
Describe USP Type-II dissolution apparatus.
05
Write a note on BCS classification system.
05
Q.5
Discuss the effect of container and closures on stability of Pharmaceutical dosage form.
06
Explain Latin square cross over design in Bioequivalence study.
05
Discuss the criteria for waivers of in vivo Bioequivalence studies.
05
Q. 6
Write a note on Bracketing matrixing design in stability study.
06
Write a note on disintegrating agents.
05
Discuss the role of solubility in Preformulation study.
05
Q.7
Write a note on Plasma Protein Drug Binding.
06
Write a note on similarity factor and difference factor in dissolution profile comparison.
05
Discuss Drug-Excipients compatibility study in detail
05
Other Question Papers
Subjects
- agronomy and forestry of medicinal plants
- anatomy physiology & health education -ii
- anatomy, physiology and health education (aphe)
- applied mathematics (biostatistics)
- basic computer applications
- basic concepts of pharmacology and clinical pharmacy practice
- basics of computer applications
- bioavailability & therapeutic drug monitoring
- bioavailability and therapeutic drug monitoring
- biochemistry
- clinical pharmacy ii
- clinical pharmacy-i
- commerce of herbs and phytoconstitutents
- computer applications in drug discovery
- current advances in novel drug delivery systems
- cyber security
- disaster management
- dispensing pharmacy i
- dispensing pharmacy i and drug store management
- dispensing pharmacy ii and pharma industrial management
- dosage form design –i
- dosage form design- i
- dosage form design- ii
- dosage form design-i
- dosage form design-ii
- drug approval process
- environmental studies
- environmental toxicology and green audit
- food analysis
- forensic pharmacy
- forensic pharmacy-i
- genetic engineering and gene therapy
- green chemistry
- health education and community health
- herbal cosmetics
- hospital and community pharmacy
- hospital management and medical tourism
- hospital pharmacy, community pharmacy & forensic pharmacy
- hospital pharmacy, community pharmacy and dispensing pharmacy-ii
- human anatomy physiology
- human anatomy physiology and health education-ii
- human anatomy physiology-ii
- human anatomy, physiology and health education - i
- innovations in conventional drug delivery system
- instrumental and process validation
- intellectual property rights and patents
- medical writing and coding
- medicinal biochemistry
- nutraceuticals
- pathophysiology
- pharmaceutical analysis ii
- pharmaceutical analysis iii
- pharmaceutical analysis iv
- pharmaceutical analysis-i
- pharmaceutical analysis-ii
- pharmaceutical analysis-iv
- pharmaceutical chemistry – ii
- pharmaceutical chemistry – vi (organic chemistry – ii)
- pharmaceutical chemistry –viii (medicinal chemistry - ii)
- pharmaceutical chemistry iii
- pharmaceutical chemistry iv
- pharmaceutical chemistry vii
- pharmaceutical chemistry-i
- pharmaceutical chemistry-i (inorganic chemistry)
- pharmaceutical chemistry-ii (physical chemistry)
- pharmaceutical chemistry-iii (biochemistry – i)
- pharmaceutical chemistry-iv (organic chemistry-i)
- pharmaceutical chemistry-ix (medicinal chemistry-iii)
- pharmaceutical chemistry-v
- pharmaceutical chemistry-v (biochemistry-ii)
- pharmaceutical chemistry-vi (medicinal)
- pharmaceutical chemistry-vii
- pharmaceutical chemistry-viii
- pharmaceutical chemistry-x
- pharmaceutical chemistry-x (medicinal chemistry-iii)
- pharmaceutical engineering
- pharmaceutical engineering-ii
- pharmaceutical inorganic chemistry
- pharmaceutical marketing management
- pharmaceutical microbiology - i
- pharmaceutical microbiology & biotechnology i
- pharmaceutical microbiology &biotechnology- ii
- pharmaceutical microbiology and biotechnology - ii
- pharmaceutical organic chemistry
- pharmaceutical technology - i
- pharmaceutical technology – i
- pharmaceutical technology- ii
- pharmaceutical technology-i
- pharmaceutical technology-ii
- pharmaceutics-i
- pharmaceutics-ii
- pharmaceutivcal chemistry ix
- pharmacognosy iii
- pharmacognosy iv
- pharmacognosy vi
- pharmacognosy vii
- pharmacognosy vii (herbal formulations & complimentary therapies)
- pharmacognosy-i
- pharmacognosy-ii
- pharmacognosy-iii
- pharmacognosy-iv
- pharmacognosy-v
- pharmacognosy-v (plant bio technology)
- pharmacognosy-vi
- pharmacology -iii
- pharmacology & pharmacotherapeutics-ii
- pharmacology and pharmacotherapeutics - i
- pharmacology and pharmacotherapeutics - iii
- pharmacology and pharmacotherapeutics-iv
- pharmacology-i
- pharmacology-ii
- pharmacovigilance
- pharmacy practice
- physical pharmaceutics-ii
- physical pharmacy
- quality by design (qbd) and process analytical technology (pat)
- regulatory aspects of food and neutraceuticals
- remedial mathematics
- unit operation - i
- unit operation - ii